BioSpace News Archive

Magnolia Medical Technologies, Inc. announced the publication of results from a study performed by United Hospital Center, a member of the West Virginia University Health System, clinically evaluating the impact of Steripath in reducing false-positive blood culture results throughout the hospital.

AmerisourceBergen, a global healthcare solutions company, today announced the establishment of AB Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with emerging healthcare startup companies working to transform healthcare for people and animals globally.

The global mHealth market size is predicted to be worth around USD 126.6 billion by 2030 and expanding growth at a CAGR of 10.0% during the forecast period 2022 to 2030.

StageZero Life Sciences, a vertically-integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, announced a corporate update and addressed the recently share price activity.

ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announces the results from the NOPHO sponsored Phase 2 trial of eryaspase in ALL patients are now published in the British Journal of Haematology.

Microbot Medical Inc., seeking to continuously enhance its core capabilities, announced the promotion of Rachel Vaknin as its Chief Financial Officer.

HTG Molecular Diagnostics, Inc. announced that it has improved the sample preparation protocol for its miRNA Whole Transcriptome Assay so that it is now harmonized with the HTG Transcriptome Panel.

ENSEM Therapeutics Inc., a Boston-based biotechnology company focusing on high value and difficult-to-drug oncology targets, announced the closing of a series A2 financing.

Haemonetics Corporation announced that the Company intends to publish fourth quarter fiscal year 2022 financial results at 6:00 am EDT on Tuesday, May 10, 2022.

CTI BioPharma Corp. announced that management will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference at 1:30 p.m. ET.